iPRI Signs MOU in Hungary
December 13, 2016
Budapest, 14 December 2016 — Today, the International Prevention Research Institute (iPRI), represented by its President, Professor Peter Boyle, concluded discussions and signed an important Memorandum of Understanding with the National Institute of Oncology of Hungary, represented by its Director Professor Miklós Kásler.
The National Institute of Oncology is the key reference for Hungary’s Ministry of Health when making decisions on cancer control policy and strategy.
The participants in this Memorandum, the International Prevention Research Institute, based in Lyon, France and The National Institute of Oncology, situated in Budapest, Hungary, share a long-standing commitment to increase capacity in Cancer Prevention. Together, they continue to strive to reduce the burden of cancer both in Hungary and in surrounding countries.
Hungary has a long tradition in medical research which stretches back many decades. Even in difficult times, the tradition of high quality cancer treatment and research has been a feature of Hungarian Medicine.
Having collaborated successfully in the past, the parties share a common interest in further strengthening relations and broadening the scope of their collaboration and academic activities.
More specifically, The International Prevention Research Institute and the National Institute of Oncology of Hungary will work together to develop training opportunities and to implement multiple Cancer Prevention, and Cancer Control activities in Hungary. Both parties will work with other Cancer Institutes world-wide to examine the effectiveness of treatments in the general population of cancer patients.